第三届国际病毒性肝炎论坛日程(中国・成都)
The 3rd International Symposium on Viral Hepatitis (Chengdu, China)
June 27 2016 (Monday) | ||||
---|---|---|---|---|
Opening Ceremony
(Chaired by Hong Tang, West China Hospital of Sichuan
University) 大会开幕(唐红主任主持, 四川大学华西医院) |
||||
8:30-9:00 | Yong Zeng, Vice
president of West China Hospital of Sichuan University四川大学华西医院曾勇副院长致欢迎词 Shuichi Kaneko, Dean of Kanazawa University Graduate School of Medical Sciences日本金沢大学研究生院院长金子周一教授致辞 Ying-Ru Lo, Coodinator of WHO Regional Office for the Western Pacific世界卫生组织西太平洋区域办事处卢颖如教授致辞 Ji Shen,Director of Health and Family Planning Commission of Sichuan Province, Director of Sichuan Medical Association 四川省卫生和计划生育委员会主任、四川省医学会会长沈骥教授致辞 |
|||
Session 1 (第一部分) | ||||
Chairs 主持人 |
Shuichi Kaneko, Dean
of Kanazawa University Graduate School of Medical
Sciences, Head of Liver Centre, Kanazawa University
Hospital 金子周一,日本金沢大学研究生院院长,日本金沢大学医院肝脏中心主任 Lan Zhang, Chief Medical Officer, China Foundation for Hepatitis Prevention & Control 张岚,中国肝炎防治基金会技术总监 |
|||
9:00-9:25 | WHO Guidelines for the
screening, care and treatment of persons with hepatitis C
infection 世界卫生组织《丙型肝炎患者筛查、关护和治疗指南》解读 |
Azumi Ishizaki WHO Geneva headquater 世界卫生组织日内瓦总部 |
||
9:25-9:50 | The WHO global and regional
viral hepatitis strategy世界卫生组织全球及区域病毒性肝炎应对策略 WHO hepatitis B guideline: adapting to the country context世界卫生组织乙型病毒性肝炎指南:面对不同国情的战略调整 |
Ying-Ru Lo(卢颖如) WPRO世界卫生组织西太平洋区域办事处 |
||
9:50-10:15 | Investing in and financing
hepatitis B and C treatment in China 中国乙型和丙型病毒性肝炎治疗的援助计划 |
Po-Lin Chan(曾宝玲) WHO Country Office - China 世界卫生组织驻华办事处 |
||
10:15-10:30 | Q&A(讨论) | |||
10:30-10:40 | Tea break茶歇(10分钟) | |||
Session 2 (第二部分) | ||||
Chairs 主持人 |
Bingjun Lei,
Professor of Centre of Infectious Diseases, West China
Hospital雷秉钧,四川大学华西医院感染性疾病中心教授 Yilan Zeng,Vice Dean of Chengdu Pulic Health Clinical Centre 曾义岚,成都市公共卫生临床医疗中心副院长 Ta Thanh Van, Vice President of Hanoi Medical University越南河内医科大学副校长 |
|||
10:40-11:05 | Co-infection of HIV and
hepatitis viruses 人类免疫缺陷病毒合并肝炎病毒感染的临床研究 |
Azumi Ishizaki Kanazawa University 日本金沢大学 |
||
11:05-11:30 | Current antiviral therapy
for chronic hepatitis in Japan 日本病毒性肝炎的抗病毒治疗现状 |
Kawaguchi Kazunori Kanazawa University 日本金沢大学 |
||
11:30-11:55 | Check-up for hepatitis
patients in Japan 日本病毒性肝炎患者的随访方案 |
Shimakami Tetsuro Kanazawa University 日本金沢大学 |
||
11:55-12:10 | Q&A(讨论) | |||
12:10-14:00 | Lunch(午餐) | |||
Session 3 (第三部分) | ||||
Chairs 主持人 |
Liansan Zhao,
Professor of Centre of Infectious Diseases, West China
Hospital赵连三,华西医院感染性疾病中心教授 Pham Van Thuc, Dean of Haiphong Medical University and Affiliated Hospital越南海防医科大学附属医院院长 Davaadorj Duger, Vice Dean for clinical affairs of Mongolian National University of Medical Sciences蒙古国立医科大学临床事务副院长 |
|||
14:00-14:25 | What can we learn from
Hepatitis B control in China 中国乙型病毒性肝炎的防控启示 |
Fuqiang Cui(崔富强) China CDC 中国疾病预防控制中心 |
||
14:25-14:50 | Treatment strategy of
chronic hepatitis B in China 中国乙型病毒性肝炎的治疗策略 |
Jinlin Hou(侯金林) Southern Medical University南方医科大学南方医院 |
||
14:50-15:15 | Hepatitis C prevalence and
control strategies in China 中国丙型肝炎流行状况及防治策略 |
Xiaochun Wang (王晓春) China CDC 中国疾病预防控制中心 |
||
15:15-15:30 | Q&A(讨论) | |||
15:30-15:40 | Tea break 茶歇(10分钟) | |||
Session 4 (第四部分) | ||||
Chairs 主持人 |
Ping Feng, Vice
Director of Centre of Infectious Diseases, West China
Hospital冯萍,四川大学华西医院感染性疾病中心副主任 Tsendsuren Oyunsuren, Head of Laboratory of Molecular Biology, Mongolian Academy of Sciences蒙古科学院分子生物学实验室主任 |
|||
15:40-16:05 | The distribution of HBV, HCV
genotypes among intravenuos drug users (IDU) and female
sex workers (FSW) in Haiphong, Vietnam 越南海防市静脉吸毒人员及女性性工作者乙型肝炎/丙型肝炎病毒基因型分布调查 |
Hung Cuong Nguyen HPMU 越南海防医药大学 |
||
16:05-16:30 | HBV and HCV infected patient
treatment in Vietnam 越南慢性乙型/丙型病毒性肝炎的治疗策略 |
Tran Ngoc Anh Hanoi Medical University 越南河内医科大学 |
||
16:30-16:55 | Effectiveness and safety of
sofosbuvir/ledispasvir treatment for monoinfected HCV
patients in Mongolia 索非布韦/雷迪帕维治疗蒙古丙型肝炎患者的疗效与安全性 |
Ariuna Sumiyadorj MNUMS 蒙古国立医科大学 |
||
16:55-17:10 | Q&A(讨论) | |||
17:10 | Closing of Day 1第一天会议结束 |
June 28 2016 (Tuesday) | ||||
---|---|---|---|---|
Session 1 (第一部分) | ||||
Chairs 主持人 |
Cunliang Deng, Vice
Dean of the affiliated hospital of Luzhou Medical College邓存良,西南医科大学附属医院副院长 Xuezhong Lei, Vice Director of Centre of Infectious Diseases, West China Hospital雷学忠,四川大学华西医院感染性疾病中心副主任 |
|||
8:30-8:55AM | Treatment strategy of chronic Hepatitis
C in China 中国丙型病毒性肝炎的治疗策略 |
Lai Wei (魏来) Peking University 北京大学人民医院 |
||
8:55-9:20AM | Innate immunity during HCV infection 丙型肝炎病毒感染过程中的固有免疫 |
Honda Masao Kanazawa University 日本金沢大学 |
||
9:20-9:45AM | The verification of HBV RNA and its
potential clinical significance HBV RNA的确证及潜在临床意义探究 |
Fengmin Lu(鲁凤民) Peking University 北京大学基础医学院 |
||
9:45-10:10AM | Research on Hepatitis B Virus X protein
(HBx): Overview and Recent Progress 乙型肝炎病毒X蛋白(HBx)研究概况和最新进展 |
Seishi Murakami(村上清史) Kanazawa University 日本金沢大学 |
||
10:10-10:25AM | Q&A(讨论) | |||
10:25-10:35AM | Tea break茶歇(10分钟) | |||
Session 2 (第二部分) | ||||
Chairs 主持人 |
Liangshi
Xiong, Director of Department of Infectious Diseases,
North Sichuan Medical College熊良仕,川北医学院感染科主任 Xiaoju Lü, Vice Director of Centre of Infectious Diseases, West China Hospital吕晓菊,四川大学华西医院感染性疾病中心副主任 |
|||
10:35-11:00 | Bio-inspired
detoxification using 3D-engneered devices 3D打印技术在生物解毒方面的应用研究 |
Malin Gou(苟马玲) Sichuan University 生物治疗国家重点实验室 |
||
11:00-11:25 | HBV X gene
integration and HBV/HDV double infection in HCC patients
in Mongolia 蒙古原发性肝癌患者乙型/丁型肝炎病毒重叠感染及乙型肝炎病毒X基因整合的临床研究 |
Lkhagvasuren Damdindorj Mongolian Academy of Science 蒙古科学院 |
||
11:25-11:50 | A HBV cccDNA
model for functional study and drug development 基于HBV cccDNA模型的功能研究及药物开发 |
Feng Li(李锋) University of North Carolina 美国北卡大学 |
||
11:50-12:05 | Q&A(讨论) | |||
12:05-14:00 | Lunch (午餐) | |||
Session 3 (第三部分) | ||||
Chairs 主持人 |
Hong Tang,Director
of the Centre of Infectious Diseases, West China Hospital
唐红,四川大学华西医院感染性疾病中心主任 Tran Ngoc Anh, Associate Professor of Hanoi Medical University越南河内医科大学副教授 |
|||
14:00-14:25 | Role of scaffold
protein JSAP in cancer 支架蛋白JASP在肿瘤发生中的作用 |
Yoshioka Katsuji Kanazawa University 日本金沢大学 |
||
14:25-14:50 | Interplay
between stromal and epithelial cells, increased
complexity in tumor microenvironment for carcinogenesis 基质细胞与上皮细胞之间的相互作用增加肿瘤微环境的复杂性 |
Yong Lin(林勇) Lovelace Institute, USA 美国Lovelace研究所 |
||
14:50-15:15 | Upregulating TNC
expression promotes hepatoma cell metastasis and is
associated with poor prognosis in HCC patients TNC高表达与肝癌转移及预后的关系 |
Lang Bai(白浪) West China Hospital 四川大学华西医院 |
||
15:15-15:30 | Q&A(讨论) | |||
15:30:15:40 | Tea break茶歇(10分钟) | |||
Session 4 (第四部分) | ||||
Chairs 主持人 |
Tetsuro
Shimakami, Assistant Professor of Kanazawa University
日本金沢大学助理教授 Kazunori Kawaguchi, Associate Professor of Kanazawa University 日本金沢大学副教授 |
|||
15:40-16:00 | Efficient
Suppression of Hepatitis C Virus Replication by
Combination Treatment with miR-122 Antagonism and Direct-acting
Antivirals in Cell Culture Systems 丙型肝炎病毒细胞复制模型中miR-122拮抗剂联合直接抗病毒药物可有效抑制病毒复制 |
Fanwei Liu (刘范伟) Kanazawa University 日本金沢大学 |
||
16:00-16:20 | HBV-induced high
expression of endoplasmic reticulum proteins in
hepatocarcinogenesis and prognosis HBV诱导的内质网蛋白高表达促进肝细胞癌发生并影响预后 |
Lingyao Du (杜凌遥) West China Hospital 四川大学华西医院 |
||
16:20-16:40 | Hepatitis B
virus X protein stimulates HBV replication by regulating
transcription factors associated with DNA or histone
methylation 乙型肝炎病毒X蛋白通过调节DNA或组蛋白甲基化相关转录因子促进HBV复制 |
Xuyang Wang(王旭阳) Kanazawa University 日本金沢大学 |
||
16:40-17:00 | Roles and
mechanism of Hepatitis B virus X protein in HBV
replication and pathogenesis 乙型肝炎病毒X蛋白在HBV复制及致病性中的作用及机制研究 |
Libo Yan (严丽波) West China Hospital 四川大学华西医院 |
||
17:00-17:20 | Q&A(讨论) | |||
17:20-17:40 | Closing
remarks of the symposium(大会闭幕) Shuichi Kaneko, Dean of Kanazawa University Graduate School of Medical Sciences日本金沢大学研究生院院长金子周一教授讲话 Hong Tang , Director of the Centre of Infectious Diseases, West China Hospital四川大学华西医院感染性疾病中心主任唐红教授讲话 |